Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARL | Q9H300 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28981837 | 0.98 | PARL (0.48) | PARLCA2CA12CA1CA9 | |
| Pyridine SCHEMBL9065176 | 0.83 | PARL (0.50) | PARL | |
| SCHEMBL28411329 | 0.79 | PARL (0.54) | PARLCA2CA12CA1CA9 | |
| SCHEMBL9064898 | 0.79 | PARL (0.34) | PARL | |
| SCHEMBL64828 | 0.75 | PARL (0.50) | PARLCA2CA12CA1CA9 | |
| SCHEMBL29748565 | 0.74 | PARL (0.46) | PARLCA2CA12CA1CA9 | |
| SCHEMBL12813400 | 0.73 | PARL (0.41) | PARL | |
| SCHEMBL7261683 | 0.72 | PARL (0.43) | PARL | |
| SCHEMBL15271986 | 0.72 | PARL (0.35) | PARL | |
| SCHEMBL10651115 | 0.71 | PARL (0.31) | PARL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805310-A | Fluorescent compounds containing hydroxy-substituted triazines and methods of making the same | 佰爱特有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-109758675-A | A kind of self-healing medical gel | 青岛中腾生物技术有限公司 | 2019-05-17 | — | — | CN | claimed |
| CN-109646709-A | A kind of medical hemostatic closed material of degradable absorption | 青岛中腾生物技术有限公司 | 2019-04-19 | — | — | CN | claimed |
| US-5556976-A | FORMING WET AND DRY RESILIENT CELLULOSE FIBERS WITH HIGH ABSORBENCY, BULK AND WET AND DRY RESILIENCY FOR PAPER TOWELS, DIAPERS AND SANITARY PRODUCTS | JEWELL RICHARD A (US) | 1996-09-17 | — | — | US | claimed |
| US-12440448-B2 | Powder, wound-covering material, adhesion prevention material, hemostatic material, and production method for powder | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2025-10-14 | — | — | US | disclosed |
| US-20250134965-A1 | ANTI-ADHESIVE MATERIAL, AND METHOD FOR PRODUCING ANTI-ADHESIVE MATERIAL | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2025-05-01 | — | — | US | disclosed |
| EP-4506021-A1 | ANTI-ADHESIVE MATERIAL, AND METHOD FOR PRODUCING ANTI-ADHESIVE MATERIAL | National Institute for Materials Science (JP) | 2025-02-12 | — | — | EP | disclosed |
| EP-4032557-B1 | BIOLOGICAL TISSUE ADHESIVE SHEET , BIOLOGICAL TISSUE REINFORCING MATERIAL KIT, AND METHOD FOR PRODUCING BIOLOGICAL TISSUE ADHESIVE SHEET | NAT INST MATERIALS SCIENCE (JP) | 2024-12-25 | — | — | EP | disclosed |
| US-12171810-B2 | Angiogenesis promoter and therapeutic method | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2024-12-24 | — | — | US | disclosed |
| EP-4032558-B1 | BIOLOGICAL TISSUE ADHESIVE SHEET, BIOLOGICAL TISSUE REINFORCING MATERIAL KIT, AND METHOD FOR MANUFACTURING BIOLOGICAL TISSUE ADHESIVE SHEET | NAT INST MATERIALS SCIENCE (JP) | 2024-11-06 | — | — | EP | disclosed |
| EP-3862016-B1 | ANGIOGENESIS PROMOTER FOR USE IN TREATING A PERIPHERAL ARTERY DISEASE | NAT INST MATERIALS SCIENCE (JP) | 2024-04-24 | — | — | EP | disclosed |
| WO-2023181563-A1 | ANTI-ADHESIVE MATERIAL, AND METHOD FOR PRODUCING ANTI-ADHESIVE MATERIAL | 国立研究開発法人物質・材料研究機構 | 2023-09-28 | — | — | WO | disclosed |
| US-6680311-B1 | ANTICARCINOGENIC, ANTITUMOR AND ANTIPROLIFERATIVE AGENTS | ELI LILLY AND COMPANY | 2004-01-20 | — | — | US | disclosed |
| EP-0934065-A4 | PHARMACEUTICAL COMPOUNDS | LILLY CO ELI (US) | 2000-10-11 | — | — | EP | disclosed |
| EP-0934065-A1 | PHARMACEUTICAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1999-08-11 | — | — | EP | disclosed |
| CN-1215164-A | Gene expression variation and protein positioning high-output analysis system | HAN XIAOLIANG (CN) | 1999-04-28 | — | — | CN | disclosed |
| WO-1998008505-A1 | PHARMACEUTICAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1998-03-05 | — | — | WO | disclosed |
| US-5556976-A | FORMING WET AND DRY RESILIENT CELLULOSE FIBERS WITH HIGH ABSORBENCY, BULK AND WET AND DRY RESILIENCY FOR PAPER TOWELS, DIAPERS AND SANITARY PRODUCTS | JEWELL RICHARD A (US) | 1996-09-17 | — | — | US | disclosed |
| US-5366591-A | Cyclic N-sulfatoimide | WEYERHAEUSER | 1994-11-22 | — | — | US | disclosed |
| WO-1993014261-A1 | METHOD FOR CROSSLINKING INDIVIDUALIZED CELLULOSE FIBRES | WEYERHAEUSER COMPANY (US) | 1993-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12171810-B2 | Angiogenesis promoter and therapeutic method | HDGF, VEGFA, EGLN2 | PARL 4584/4885CA2 1227/4885CA12 1658/4885 |
| US-12440448-B2 | Powder, wound-covering material, adhesion prevention material, hemostatic material, and production method for powder | COL2A1, COL1A1, F12 | PARL 3697/4885CA2 1959/4885CA12 1744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.